We know that lowering the level of
mutant huntingtin protein in HD mouse models significantly improves symptoms reminiscent of HD, providing hope that similar treatments in people may be effective.
Clumps
of mutant huntingtin protein in brain cells are a hallmark of HD, and they build up slowly, occupying more and more cells over time.
The phase 1 / 2a study of IONIS - HTTRx was recently completed and showed the therapy to be safe and well - tolerated but also showed it's ability to reduce the level of
mutant huntingtin in a dose dependent manner in Huntington's Disease patients.
The researchers worked to identify ways to prevent VCP from heading to nerve cell mitochondria and interacting
with mutant huntingtin protein once inside.
Huntingtin is useful, but in HD, an abnormal form of the protein called
mutant huntingtin causes damage, kills neurons and eventually produces the symptoms of the disease.
Qi and colleagues discovered that VCP is recruited to nerve cell mitochondria
by mutant huntingtin protein.
There are many ways of achieving the goal of
lowering mutant huntingtin, expected to start new trials soon or already in early trials.
In an announcement likely to stand as one of the biggest breakthroughs in Huntington's disease since the discovery of the HD gene in 1993, Ionis and Roche today announced that the first human trial of a huntingtin - lowering drug, IONIS - HTTRx, demonstrates that it
reduces mutant huntingtin in the nervous system, and is safe and well - tolerated.
In humans, Huntington's is an inherited disease caused by a gene encoding a toxic protein,
called mutant huntingtin, which causes brain cells to die.
This abnormal binding causes more VCP accumulation on the mitochondria,» Nerve cells with VCP -
mutant huntingtin interacting inside them became dysfunctional and self - destructed.
Mochly - Rosen and colleagues identified several other potential biomarkers that were elevated in HD model mice, including the levels of 8 - hydroxy - deoxy - guanosine, a product of oxidative DNA damage, in the urine and the presence of
mutant huntingtin aggregates and oxidative damage in muscle and skin cells.
«Because mitochondrial dysfunction has been proposed to play an important role in the pathogenesis of Huntington's disease,» said Qi, «we investigated the binding proteins of
mutant huntingtin on mitochondria.»
Electrophysiological studies in basal ganglia slices from symptomatic transgenic BACHD rats carrying full
length mutant huntingtin has shown increased GP and decreased STN firing consistent with this hypothesis1.
Designing drugs that tell our cells to make less of the
harmful mutant huntingtin protein is one of the most promising approaches to treating Huntington's disease.
Some of these approaches to
attack mutant huntingtin also reduce levels of the normal protein, including the Ionis huntingtin - lowering drug.
Emphasising their desire to move the drug forward, in a separate announcement made directly to the HD community, Ionis said «Upon study completion, the next step for this program will be to conduct a study to investigate if
decreasing mutant huntingtin protein with IONIS - HTTRx can slow the progression of this terrible disease.»
In March Chris Ross and his colleagues reported that cells
bearing mutant huntingtin could survive if they produced extra CBP.
Being able to detect and measure the amount of
mutant huntingtin present in the nervous system will be a valuable way of seeing whether the gene - silencing drug is hitting its target and has the intended effect, lowering the amount of disease causing mHTT protein.
Published in the Journal of Clinical Investigation, the research team behind the findings hope that the new assay will enable the testing of drugs that aim to lower the production of the
pathogenic mutant huntingtin protein that causes the disease, and could be useful in predicting or monitoring the progression of HD.
In July, Elena Cattaneo and her colleagues at the University of Milan reported that
mutant huntingtin affects another key neuron - survival protein called brain - derived neurotrophic factor (BDNF).
The international team of scientists from University College London, IRBM Promidis, University of British Columbia, and CHDI Foundation developed a new ultra-sensitive test using the Singulex SMC Technology Erenna Immunoassay system that is able to
detect mutant huntingtin in the cerebrospinal fluid (CSF) of HD patients, including some who carry the HD mutation but have not yet developed symptoms.
A new clinical trial just announced for 2015 aims to test a «huntingtin lowering» therapy, called an antisense oligonucleotide (ASO), that attacks
mutant huntingtin directly.
Surprisingly, the research team noticed clear differences in the ability of different types of neurons to
clear mutant huntingtin.
Another option may be the pursuit of «allele - specific» therapies, those that specifically
target mutant huntingtin while leaving the normal form intact.
For example, if we
block mutant huntingtin production in cells or animals with «gene silencing» techniques, how can we confirm that this treatment actually does what it's supposed to do in the brains of patients with HD?
Project Title: In vivo genome - wide genetic screening for modifiers of mutant Huntingtin toxicity
Given the adult onset and dysfunction and death of adult neurons characterizing HD, most studies have focused on the toxic effects elicited
by mutant huntingtin in post-mitotic neurons.
One of the earliest events in HD is that
mutant huntingtin aggregates disrupt the function of mitochondria, lowering cellular energy levels and causing oxidative damage.
When they stained brain samples taken from human Huntington's victims, they found that the characteristic globs consist of full -
length mutant huntingtin, rather than peptide fragments from the mutant.
After an exciting day of science yesterday, day 2 saw updates on strategies to rid cells of the
harmful mutant huntingtin protein and exciting reports on current and planned clinical trials.
Ionis said: «the next step for this program will be to conduct a study to investigate if
decreasing mutant huntingtin protein with IONIS - HTTRx can slow the progression of this terrible disease.»
Blocking nuclear export seemed to prevent cells from dying and counteracted the defects in neurons
with mutant Huntingtin, the researchers say.
We've known for a little while that drugs that interfere with mTOR decrease levels
of mutant huntingtin protein by helping cells destroy it after it's made.
Animal studies have revealed strong benefits of these techniques, showing that reducing
mutant huntingtin in the brains of HD mice can improve their brain health and behavior.
Huntington's disease is caused by a gene encoding a toxic protein (
mutant huntingtin) that causes brain cells to die.
Xin Qi, PhD, assistant professor of physiology and biophysics at Case Western Reserve University School of Medicine has been looking for proteins that interact with
mutant huntingtin to better understand the initial steps of Huntington's disease progression.
University of California, Irvine neurobiologists Leslie Thompson and Joseph Ochaba with the Departments of Neurobiology & Behavior and Psychiatry & Human Behavior and their colleagues from UCI and from Children's Hospital of Philadelphia have shown that reducing the aberrant accumulation of a particular form of
the mutant Huntingtin protein corresponds to improvement in symptoms and neuroinflammation in HD mice.
«The damage caused by
the mutant huntingtin protein radiates out through the cell, like a pebble dropped in a pond.
Phrases with «mutant huntingtin»